Pharma False Science – Celexa
In the late 1990s/mid 2000s, Forest Laboratories illegally promoted its antidepressant Celexa (citalopram) for use in children and adolescents, even though it was only approved… Read More »Pharma False Science – Celexa
In the late 1990s/mid 2000s, Forest Laboratories illegally promoted its antidepressant Celexa (citalopram) for use in children and adolescents, even though it was only approved… Read More »Pharma False Science – Celexa
For the release of its antidepressant Zoloft in the late 1990s and early 2000s, Pfizer orchestrated a ghostwriting program in which a medical communications company… Read More »Pharma Fraudulent Marketing – Zoloft – Ghost Writing
“A small minority of patients treated with ECT later report devastating cognitive consequences. Patients may indicate that they have dense amnesia extending far back into… Read More »ECT – Psychiatry’s Russian Roulette
Still no validated causes, no cures, and no practical tools that actually help people labelled “mentally ill.”
In places that claim to offer care and healing for the mentally vulnerable, too many have instead found further violation.
The Special Children’s Killing Wards. The killing of children was part of Aktion T4; it was where it began.
Sitting Duck Syndrome: Why Incest Survivors (and Other High-Risk Patients) Are Prime Targets for Therapist Sexual Abuse
The latest research from Australia delivers a stark, data-driven indictment of psychiatry’s primary “solution” for attention deficit hyperactivity disorder.
In the Nineteenth century psychiatry promised a new dawn for mental health. Instead, it has delivered a perpetual night of symptom suppression, ever-expanding diagnoses, and a pharmaceutical profit machine that treats patients as repeat customers.
The author argues that the system is designed to “produce patients rather than health” by medicalising normal human distress and making support dependent on receiving a formal diagnosis.
…the most important part of a resident’s curriculum is the art and quasi-science of dealing drugs, i.e., prescription writing.
A January 2024 study using machine learning analysis of neuroscience findings failed to find any biomarkers for Major Depressive Disorder.